Status:
COMPLETED
A Safety and Efficacy Study of Fixed-Combination Bimatoprost and Brimonidine in Chronic Glaucoma or Ocular Hypertension
Lead Sponsor:
Allergan
Conditions:
Glaucoma
Ocular Hypertension
Eligibility:
All Genders
40+ years
Phase:
PHASE2
Brief Summary
This is a safety and efficacy study of fixed-combination bimatoprost and brimonidine compared with LUMIGAN® and ALPHAGAN® in patients with chronic glaucoma or ocular hypertension.
Eligibility Criteria
Inclusion
- Diagnosis of ocular hypertension or glaucoma
- Requires intraocular pressure (IOP)-lowering therapy
Exclusion
- Cataract surgery in one eye
- Ocular laser or intraocular surgery within 6 months
- Refractive surgery in either eye
- Anticipated use of contact lenses during the study
- Expected use of artificial tears during the study
Key Trial Info
Start Date :
June 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2013
Estimated Enrollment :
112 Patients enrolled
Trial Details
Trial ID
NCT01863953
Start Date
June 1 2013
End Date
December 1 2013
Last Update
January 26 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Newport Beach, California, United States